Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial.
Asphyxia Neonatorum
/ physiopathology
Bradycardia
/ therapy
Bronchopulmonary Dysplasia
/ etiology
Female
Functional Residual Capacity
Gestational Age
Heart Rate
Hospital Mortality
Humans
Infant
Infant Mortality
Infant, Extremely Premature
Infant, Newborn
Intensive Care Units, Neonatal
Intermittent Positive-Pressure Ventilation
Male
Positive-Pressure Respiration
/ adverse effects
Resuscitation
/ methods
Journal
JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160
Informations de publication
Date de publication:
26 03 2019
26 03 2019
Historique:
entrez:
27
3
2019
pubmed:
27
3
2019
medline:
4
4
2019
Statut:
ppublish
Résumé
Preterm infants must establish regular respirations at delivery. Sustained inflations may establish lung volume faster than short inflations. To determine whether a ventilation strategy including sustained inflations, compared with standard intermittent positive pressure ventilation, reduces bronchopulmonary dysplasia (BPD) or death at 36 weeks' postmenstrual age without harm in extremely preterm infants. Unmasked, randomized clinical trial (August 2014 to September 2017, with follow-up to February 15, 2018) conducted in 18 neonatal intensive care units in 9 countries. Preterm infants 23 to 26 weeks' gestational age requiring resuscitation with inadequate respiratory effort or bradycardia were enrolled. Planned enrollment was 600 infants. The trial was stopped after enrolling 426 infants, following a prespecified review of adverse outcomes. The experimental intervention was up to 2 sustained inflations at maximal peak pressure of 25 cm H2O for 15 seconds using a T-piece and mask (n = 215); standard resuscitation was intermittent positive pressure ventilation (n = 211). The primary outcome was the rate of BPD or death at 36 weeks' postmenstrual age. There were 27 prespecified secondary efficacy outcomes and 7 safety outcomes, including death at less than 48 hours. Among 460 infants randomized (mean [SD] gestational age, 25.30 [0.97] weeks; 50.2% female), 426 infants (92.6%) completed the trial. In the sustained inflation group, 137 infants (63.7%) died or survived with BPD vs 125 infants (59.2%) in the standard resuscitation group (adjusted risk difference [aRD], 4.7% [95% CI, -3.8% to 13.1%]; P = .29). Death at less than 48 hours of age occurred in 16 infants (7.4%) in the sustained inflation group vs 3 infants (1.4%) in the standard resuscitation group (aRD, 5.6% [95% CI, 2.1% to 9.1%]; P = .002). Blinded adjudication detected an imbalance of rates of early death possibly attributable to resuscitation (sustained inflation: 11/16; standard resuscitation: 1/3). Of 27 secondary efficacy outcomes assessed by 36 weeks' postmenstrual age, 26 showed no significant difference between groups. Among extremely preterm infants requiring resuscitation at birth, a ventilation strategy involving 2 sustained inflations, compared with standard intermittent positive pressure ventilation, did not reduce the risk of BPD or death at 36 weeks' postmenstrual age. These findings do not support the use of ventilation with sustained inflations among extremely preterm infants, although early termination of the trial limits definitive conclusions. clinicaltrials.gov Identifier: NCT02139800.
Identifiants
pubmed: 30912836
pii: 2728923
doi: 10.1001/jama.2019.1660
pmc: PMC6439695
doi:
Banques de données
ClinicalTrials.gov
['NCT02139800']
Types de publication
Comparative Study
Journal Article
Multicenter Study
Pragmatic Clinical Trial
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1165-1175Subventions
Organisme : NICHD NIH HHS
ID : U01 HD072906
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Références
Am J Respir Crit Care Med. 2001 Jun;163(7):1723-9
pubmed: 11401896
Pediatrics. 2001 Aug;108(2):E35
pubmed: 11483845
J Perinatol. 2003 Sep;23(6):451-6
pubmed: 13679930
Sci Am. 1963 Oct;209:27-35
pubmed: 14070113
ACP J Club. 2004 Mar-Apr;140(2):A11
pubmed: 15122874
Arch Dis Child Fetal Neonatal Ed. 2005 Sep;90(5):F406-10
pubmed: 15863490
Acta Paediatr. 2005 Mar;94(3):303-9
pubmed: 16028648
Pediatrics. 2007 Aug;120(2):322-9
pubmed: 17671058
N Engl J Med. 2008 Feb 14;358(7):700-8
pubmed: 18272893
Pediatr Res. 2009 May;65(5):537-41
pubmed: 19190537
N Engl J Med. 2010 May 27;362(21):1970-9
pubmed: 20472939
Eur J Med Res. 2010 Nov 25;15(11):493-503
pubmed: 21159574
Pediatr Res. 2011 Jul;70(1):56-60
pubmed: 21659961
Pediatrics. 2012 Mar;129(3):480-4
pubmed: 22371462
Pediatrics. 2014 Jul;134(1):e1-3
pubmed: 24913792
J Pediatr. 2014 Nov;165(5):903-8.e1
pubmed: 25039041
Arch Dis Child Fetal Neonatal Ed. 2015 Jul;100(4):F361-8
pubmed: 25550472
Pediatrics. 2015 Feb;135(2):e457-64
pubmed: 25624390
Trials. 2015 Mar 15;16:95
pubmed: 25872563
PLoS One. 2015 Sep 25;10(9):e0138964
pubmed: 26406467
Pediatrics. 2015 Nov;136 Suppl 2:S120-66
pubmed: 26471381
Circulation. 2015 Nov 3;132(18 Suppl 2):S543-60
pubmed: 26473001
Resuscitation. 2015 Oct;95:249-63
pubmed: 26477415
J Perinatol. 2016 Jun;36(6):443-7
pubmed: 26820220
Cochrane Database Syst Rev. 2016 Jun 14;(6):CD001243
pubmed: 27315509
J Matern Fetal Neonatal Med. 2017 Jun;30(11):1273-1278
pubmed: 27384245
Arch Dis Child Fetal Neonatal Ed. 2017 Jan;102(1):F90-F91
pubmed: 27515986
Clin Perinatol. 2016 Dec;43(4):633-646
pubmed: 27837749
Resuscitation. 2017 Feb;111:68-73
pubmed: 27987395
Front Pediatr. 2017 Mar 21;5:56
pubmed: 28377915
Arch Dis Child Fetal Neonatal Ed. 2017 Nov;102(6):F525-F531
pubmed: 28596379
Cochrane Database Syst Rev. 2017 Jul 14;7:CD004953
pubmed: 28707404
Pediatrics. 2018 Jan;141(1):
pubmed: 29288162
J Pediatr. 1978 Apr;92(4):529-34
pubmed: 305471
Proc R Soc Med. 1966 Jun;59(6):508
pubmed: 5949299
J Pediatr. 1981 Oct;99(4):635-9
pubmed: 7277110
J Biopharm Stat. 1998 Mar;8(1):87-102
pubmed: 9547429